每年7月8日世界过敏性疾病日，旨在唤起全球对过敏问题的重视。职业环境中的粉尘、化学因子等致敏 原已经成为了劳动者健康的隐形挑战，以"渝承守护 西续力量"为核心理念的第109届中国国际劳动保护 用品交易会，汇聚从头到脚的个体防护装备创新成果，为职业健康防护领域搭建集技术展示、行业对 话、产业升级于一体的专业平台，为制造业、医疗、农业、能源等领域的劳动者构筑起科技赋能的健康 防线。 世界过敏性疾病日聚焦于全球日益严峻的过敏健康威胁，而职业环境中的过敏风险与职业健康安全问题 紧密相关。在化工工业、纺织、食品加工等行业，从业者长期暴露于化学试剂、粉尘、生物过敏原等有 害物中，易引发呼吸道过敏、接触性皮炎等病症，不仅损害个人健康，更可能影响工作效率与生活质 量。个体防护装备(PPE)作为职业健康安全的最后一道防线，在预防职业性过敏方面发挥关键作用。通 过科学选择、正确使用个体防护装备，结合良好的通风系统与工作流程优化，可显著降低职业环境中的 过敏风险，推动职业健康安全体系的完善，助力实现劳动者的健康福祉与企业可持续发展的双赢目标。 防护经纬：科技织就安全网 在劳保会现场，您将看到丰富多元的展品构建起的职业防护立体网络。 ...

本报记者 张晓玉 花一杯奶茶钱拿下总资产过亿元的企业？资本市场正上演"白菜价"收购。 近日，中红普林医疗用品股份有限公司（股票代码：300981，以下简称"中红医疗"）发布的公告显示，公司全资子公司中 红国际（香港）商贸有限公司（以下简称"中红香港"）与控股子公司桂林恒保防护国际有限公司（以下简称"恒保国际"）签署 股份买卖协议，以合计6.97元收购东南亚SEA3公司（以下简称"SEA3"）75%股权。 添翼数字经济智库高级研究员吴婉莹对《证券日报》记者表示，中红医疗以6.97元"白菜价"收购东南亚SEA3公司75%股 权，表面是低价获取上亿资产，但考虑到该企业净资产持续为负、年亏损超1800万元的现状，实质是"承债式收购高风险标 的"，而超低交易价正反映了其资不抵债现状；中红医疗需后续增资超7500万元填补亏损并重启运营，核心目标是利用SEA3的 东南亚生产基地及欧美认证资质。需要注意的是，此次投资面临着收购标的经营持续恶化、跨文化管理及行业竞争等三重挑 战，投资成败取决于战略协同效能的落地情况。 布局东南亚产能抢占全球市场 交易完成后，中红香港与恒保国际将分别向SEA3增资5297.55万元和2270.3 ...

以下文章来源于e公司 ，作者证券时报 曾剑 拟并购标的总资产上亿 SEA3公司成立于2016年9月，注册地位于东南亚，注册资本为6333万元。公司股东包括SEA3集团以及6名自然人。上市公司称交易对手与其不存在关 联。 e公司 . e公司，证券时报旗下专注上市公司新媒体产品，立志打造A股上市公司资讯第一平台。提供7x24小时上市公司标准化快讯，针对可能影响上市公司股价 的主题概念、行业事件及时采访二次解读，从投资者需求出发，直播上市公司有价值的活动、会议。 花几块钱就能在东南亚买下一家资产上亿的企业？此事真实发生。 中红医疗（300981）近日披露，其全资子公司中红香港、下属桂林恒保防护国际有限公司（下称"桂林恒保"）签署股份买卖协议和股东协议， 收购东 南亚SEA3公司（下称"SEA3公司"）合计75%股权。 证券时报·e公司记者注意到，SEA3公司75%股权的交易价格仅为6.97元，由中红香港、桂林恒保分别支付4.88元和2.09元。 中红医疗主要从事高品质一次性健康防护用品、医用无菌器械等产品的研发、生产与销售，属于医疗器械行业。 公司产品包括一次性健康防护手套、安 全输注产品（注射器、输液器等）、避孕 ...

Core Viewpoint - 康隆达's acquisition of Jiangxi Tiancheng Lithium Industry Co., Ltd. has led to significant financial losses due to unmet performance commitments, resulting in regulatory penalties for the counterparties involved [1][6]. Group 1: Acquisition and Performance Commitments - 康隆达 acquired a 17.67% stake in Tiancheng Lithium for 212 million yuan in September 2022, making it a subsidiary [1][4]. - The performance commitments for Tiancheng Lithium were set at net profits of no less than 180 million yuan, 200 million yuan, and 210 million yuan for the years 2022, 2023, and 2024, respectively [4]. - Tiancheng Lithium achieved a total net profit of 267 million yuan from 2022 to 2024, resulting in a performance completion rate of 45.2% [4]. Group 2: Financial Impact - 康隆达 reported a cumulative loss of 706 million yuan in net profit for 2023 and 2024, primarily due to the underperformance of Tiancheng Lithium [2][9]. - The company recognized goodwill impairment losses totaling 396 million yuan related to the acquisition of Tiancheng Lithium [2][9]. - In 2022, 康隆达's revenue was 1.374 billion yuan, a 30.55% increase year-on-year, but the company faced losses in subsequent years due to the underperformance of its lithium segment [8][9]. Group 3: Regulatory Actions - The Zhejiang Securities Regulatory Bureau imposed corrective measures on the performance commitment parties for failing to fulfill their obligations, which will be recorded in the securities market integrity archives [1][6]. - 康隆达 has indicated plans to pursue legal avenues to recover the 116 million yuan in cash compensation owed by the performance commitment parties [7]. Group 4: Business Operations - 康隆达's main business remains in protective gloves, with significant revenue contributions from this segment despite challenges in the lithium business [9]. - The company is also developing a production base in Vietnam for its protective glove products, which is expected to enhance revenue in 2025 [10].

Core Viewpoint - 康隆达 faces significant challenges due to the failure of its subsidiary, 天成锂业, to meet performance commitments, leading to regulatory actions and financial losses [1][3][5] Group 1: Company Performance and Financials - 康隆达's stock price has dropped from a peak of 56.48 yuan per share in June 2022 to 14.41 yuan per share by the end of 2024, representing a cumulative decline of 74.49% [3] - The company reported a total net loss of 706 million yuan over 2023 and 2024, with 天成锂业 achieving only 267 million yuan in net profit against a commitment of 590 million yuan over three years, resulting in a performance completion rate of 45.20% [3][4] - 康隆达 received a total of 1.16 billion yuan in cash compensation from 天成管理 and 亿源锂 due to the unmet performance commitments [3] Group 2: Regulatory Actions - 浙江证监局 issued a decision requiring 天成管理, 亿源锂, and others to rectify their failure to fulfill performance commitments, marking this as a violation of their obligations [1][5] - The Shanghai Stock Exchange also imposed disciplinary actions against the involved parties, including public reprimands, due to the violations [1][5] Group 3: Market Context and Future Outlook - 康隆达's involvement in the lithium sector initially brought substantial returns, with revenues from "lithium salts" and "lithium salt processing" reaching 721.35 million yuan and 1.80 billion yuan respectively in 2022, with gross margins significantly higher than its core business of functional gloves [2] - Despite recent stock price recovery, the company announced the termination of its "annual production of 2400 tons of multifunctional, high-performance polyethylene fiber project," reallocating the remaining funds to supplement working capital [6]

Core Viewpoint - Jiangsu Henghui Security Co., Ltd. maintains a stable credit rating of AA- with a positive outlook, reflecting its competitive position in the functional safety glove market and ongoing expansion efforts [3][5][8]. Company Overview - Jiangsu Henghui Security Co., Ltd. is a publicly listed company in China specializing in the production of functional safety gloves, possessing certain technological and channel advantages in its niche market [8][10]. - The company has expanded its production capacity and is extending its industrial chain upstream, which enhances its competitiveness [8][10]. Financial Performance - As of March 2025, the total assets of the company reached 26.13 billion yuan, with total liabilities at 10.93 billion yuan and total equity at 15.20 billion yuan [7]. - The company reported a significant increase in operating revenue, with projections indicating a rise from 9.77 billion yuan in 2023 to 12.70 billion yuan in 2024 [7][26]. - The gross profit margin for the company was 22.03% in 2024, reflecting a decrease from previous years due to rising costs and competitive pricing pressures [26]. Market Position - The functional safety glove market is primarily dominated by developed countries such as Europe, the United States, and Japan, where safety awareness and labor protection systems are well established [10][11]. - The market for functional safety gloves in China is still developing, with significant growth potential as safety awareness increases [10][11]. Production Capacity and Strategy - The company has a production capacity of 1.44 billion pairs of gloves per year, with a focus on both special fiber and general fiber gloves [20][21]. - The company is actively investing in new projects, including a 7.2 million pairs per year safety glove project and a biodegradable polyester rubber project, to enhance its product offerings and market reach [24][25]. Risk Factors - The company faces risks related to geopolitical tensions, macroeconomic fluctuations, and raw material price volatility, which could impact its operational performance [3][4][10]. - The competitive landscape in the functional safety glove industry is intensifying, necessitating continuous innovation and market adaptation [10][11]. Future Outlook - The company is expected to maintain a stable credit level in the future, supported by its ongoing expansion and diversification efforts [5][6]. - The demand for high-performance polyethylene fibers is projected to grow, providing opportunities for the company to enhance its product offerings and market position [14][23].

【DT新材料】 获悉，6月11日， 康隆达 公告，公司决定终止 "年产2400吨多功能、高性能高强高模聚乙烯纤维项目" ，并将该项目剩余募集资金8972 万元永久补充流动资金。该事项尚需提交公司股东大会审议批准。 截至24年6月公司的超高分子量聚乙烯（UHMWPE）纤维产能约为1000吨/年，部分自用、部分出售以国防和警用领域为主。海外 帝斯曼 、 霍尼韦尔 等公司已有将这一材料应用于机器人灵巧手腱绳材料。 2022年以来， 受外部经济环境变化、行业增速放缓、业内产能需求结构调整等因素的影响，为提高募集资金使用效率 ，公司主动放缓投资进度，分别 于2022年5月、2024年5月进行了项目延期。截至目前，上述情况未得到明显改善，经全面评估后，公司决定终止该项目的后续实施。主要原因如下： （1）行业增长放缓，导致现有产能已能够满足下游需求 短期来看，受下游需求不及预期影响，现有产能已能够满足公司防切割手套用丝和外部客户的需求，若继续投入建设新生产线，将造成产能闲置问题。 2025第四届复合材料界面论坛 THE 4* COMPOSITE INTERFACES FORUM 2025 ② 2025年7月16-18日 | ...

恒辉安防（300952）在机器人灵巧手腱绳等领域的布局进展，一直是市场关注的热点。5月26日，恒辉 安防披露的调研纪要中提到，公司已经开发出多款腱绳测试样品，关键技术指标均达到预期效果。针对 机器人灵巧手腱绳、关节防护及外壳刚性材质等应用场景，公司研发团队已与多家机器人企业开展技术 交流与样品送测工作，部分客户反馈良好，正在进行进一步的合作可行性评估。 为有效化解关税政策带来的不确定性风险，恒辉安防除加速推进越南工厂产能建设，增强接单竞争优势 之外，公司积极实施多元化市场战略：一方面，持续加大对欧盟、南美、非洲、澳洲等新兴市场的资源 投入，凭借前瞻性的战略布局与高效的市场响应能力，在新兴市场已取得显著突破，业绩呈现高速增长 态势；另一方面，深耕国内市场，依托"高品质、快交付、低成本"的核心竞争优势，加速市场渗透，全 力构建"国内+国际"双轮驱动的增长格局。 公告同时显示，越南"年产1,600万打功能性安全防护手套项目"进展顺利，符合预期，正稳步开展设备 安装调试、公用工程系统搭建及前期运营物料筹备等工作，"公司计划于6月底启动部分产线试生产，力 争7月份实现首批订单交付。"证券时报.e公司记者注意到，恒辉安防 ...

Core Viewpoint - The recent change in the shareholding structure of Bluestar Medical has raised concerns among investors regarding potential interests transfer and the implications of the new indirect controlling shareholder, Langhui Chemical [3][4][5] Group 1: Shareholding Changes - Langhui Chemical has acquired a controlling stake in Bluestar Medical's major shareholder, Zibo Bluestar Investment, through a capital increase, diluting the stake of Bluestar Group from 98% to 47.0013% [5][6] - Despite the change in indirect control, the actual controller, Li Zhenping, remains unchanged, and the company asserts that this does not affect the control or business structure of Bluestar Medical [5][6][9] Group 2: Financial Performance and Transactions - Langhui Chemical, previously a loss-making subsidiary, has transformed into a leading enterprise in the plasticizer and resin sector, with revenues of approximately 12.15 billion, 12.69 billion, and 13.42 billion from 2022 to 2024 [6][11] - Bluestar Medical has reported continuous losses over the past three years, with revenues of approximately 4.9 billion, 4.93 billion, and 6.25 billion, and net losses of approximately 372 million, 568 million, and 446 million during the same period [11] Group 3: Supply Chain and Procurement - Langhui Chemical has been the largest supplier for Bluestar Medical over the past three years, with procurement amounts of approximately 499 million, 496 million, and 577 million, accounting for 15.27%, 12.88%, and 12.52% of total annual procurement [9][10] - Bluestar Medical plans to procure approximately 635 million from Langhui Chemical in 2025, which is significantly higher than from other suppliers, indicating a reliance on this supplier despite the commitment to reduce related transactions [10][11]

此次活动由市人力资源和社会保障局主办，旨在通过多元化宣传形式筑牢工伤预防防线、守护劳动者的安全与健康。省人力资源和社 会保障厅以及市卫生健康委员会、市应急管理局、市经济和信息化局、市财政局、市交通运输局、市住房和城市更新局、市总工会等7家 工伤预防联席会议成员单位受邀参加。 5月16日，市人力资源和社会保障局会同相关部门，在武汉市民之家南广场举办"稳定就业，工伤预防，为'汉'护航"系列宣传活动暨武 汉工伤预防主题展。 高空作业"十不准"是什么？加油站作业工伤预防有哪些细节要注意？主题展区设置了宣传科普区、VR体验区、急救技能培训区、互动 游戏区、防护用品展示区、合影打卡区等六大互动板块，展示了工伤预防政策与案例。市民戴上VR设备，身临其境地感受高空作业、火灾 逃生等场景，通过模拟体验来提高安全意识。 在防护用品展示区，安全帽、防护手套、安全警示服装等防护用品一字排开。市民陈先生感叹："大开眼界，原来在不同工作场景下要 用上的防护用品有这么多种类。" 互动游戏区里，宇树机器人一亮相就吸引了众多市民参与转盘答题、机器人问答等创意游戏，大家在游戏中学到了更多工伤预防知 识。 现场还有专家为市民带来工伤急救知识培训， ...